Brief: Microport Scientific Posts HY Net Profit Attributable Of Shanghai Microport Endovascular Medtech RMB215.0 Million
25/08/2022 15:25
Aug 25 (Reuters) - Microport Scientific Corp 0853.HK :
* HY NET PROFIT ATTRIBUTABLE OF SHANGHAI MICROPORT
ENDOVASCULAR
MEDTECH RMB215.0 MILLION VERSUS RMB184.7 MILLION
* HY REVENUE FOR SHANGHAI MICROPORT ENDOVASCULAR MEDTECH
(GROUP)
RMB458.8 MILLION VERSUS RMB362.3 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1tWV0J
Further company coverage: 0853.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort Scientific
See all newsBrief: Microport Scientific Says Delay In Publication Of Interim Results
Brief: Microport Scientific Announces Delay In Publication Of 2026 Interim Results
Brief: Microport Scientific Says Shanghai Microport Endovascular Medtech Logs HY Revenue Of RMB793.95 Million
Brief: Microport Scientific Sees 12%-14% Y/Y Revenue Growth In Continuing Operations For HY
Brief: Microport Scientific Unit And Others To Sell 62% Of Shanghai Microport Orthopedics To Tinavi